Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years

Added 152 days ago (28.04.2021)
Authors: Mark H Einstein; Mira Baron; Myron J Levin; Archana Chatterjee; Bradley Fox; Sofia Scholar; Jeffrey Rosen; Nahida Chakhtoura; Dorothée Meric; Francis J Dessy; Sanjoy K Datta; Dominique Descamps; Gary Dubin; HPV-010 Study Group
Read article